Drug Delivery Partnering Terms and Agreements

Pages » 2427
Published By » Current Partnering
Price » $2995
In stock
View Report Details
Description

The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.   The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors d...


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jan 2014
Price: $2995
Orphan Drugs Partnering Terms and Agreements
The Orphan Drugs Partnering Terms and Agreements report provides an understanding and access to the orphan drugs partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in orphan drugs partnering deals Disclosed headlines, upfronts, milestone
Published Date: Aug 2013
Price: $1795
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Sep 2013
Price: $2795
Companion Diagnostics Partnering Terms and Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe companion diagnostics partnering deals and agreements entered intby the worlds leading healthcare companies.   The report provides a detailed underst
Published Date: Oct 2013
Price: $1795
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provide
Published Date: Sep 2013
Price: $2795

 


 

Related News

Election of Stable Government Could Push USD 30 billion M&A Deals in India
Market watchers opine that the Indian market for mergers and acquisitions is poised to witness increase momentum following the general elections that are currently underway in the world’s largest democracy. Analysts believe that post the general elections, the total value of M&A deals could well be over USD 30 billion, if a stable government is elected at the center in the current Lok Sabha polls. Experts predict the pace of inbound deals to be much higher following the elections
Date: Apr 15

Beshear Promotes a Group to Boost Auto Industry in Kentucky
Kentucky seeks to be closely identified with the auto industry same as Detroit, says Gov. Steve Beshear when he launched the Kentucky Automotive Industry Association on Monday.  Beshear said at a Capitol news conference that the group aims to be the voice and unified icon for an industry sector that is important to our state’s growing economic health and growth. He added that the association is focusing on branding, leadership, and advocacy, and similarly, 12 other states have such
Date: Apr 08

Alibaba Founder Invests USD 531.78 in Financial Software Enterprise
Chinese billionaire Jack Ma, who is credited for founding the world’s largest e-commerce firm Alibaba Group Holding, is investing USD 531.78 million to gain a controlling share in Hundsun Technologies Inc, a financial software firm. Hundsun Group-that controls a 20.6% stake in Hundsun Technologies-would sell its entire stake in the latter to Zhejiang Finance Credit Network Technology Co, a company in which Ma owns a 99% stake.  This deal will render Ma a controlling stake in Hun
Date: Apr 03

Rising Air Pollution Spur Chinese Citizens to Import Fresh Mountain Air in Vacuum Packed Bags
Air pollution levels in China have mounted to levels such high that even a spurt of fresh air these days seems like a matter of past. The situation is clearly visible from the most recent attack of thick smog in Zhengzhou (the city is still gulped by it), the capital of Henan province, one of China’s 10 most polluted places.  Citing the ever increasing levels of air pollution, many people have opted to move out of polluted cities in China. But life is not easy for the ones who st
Date: Apr 02

8.2 Magnitude Earthquake in Chile Triggers Tsunami Warnings
A high magnitude earthquake that measured 8.2 richters struck off the coasts of Chile this Tuesday night. The earthquake caused landslides and triggered a small Tsunami on Chile’s coastline. The centre of the earthquake was about 60 miles northwest of the town Iquiqe.   The hustle created by the earthquake also resulted in fleeing of more than 300 prisoners from a jail. This has led the military to take control over the town to prevent any mishaps. Emergency officials have reported
Date: Apr 02

Apple Files Petition for Patent of Innovative Technology That Makes Texting While Walking Safer
You can now let go of your worries of getting bumped on a pole or getting stumped while walking just because your eyes are glued to your smartphone’s screen and you are too busy concentrating at texting while walking.  US technology giant Apple is soon to introduce a technology (it has already filed a petition for its patent) that does not even require you to pull your head out of your phone and look around - a live video feed of anything that is in the front of you, or essentially
Date: Apr 01

U.S. FDAs Stamp of Approval for Xolair Drug Developed by Novartis and Genentech
The United States Food and Drug Administration (FDA) has stamped its mark of approval for Xolair (omalizumab), a drug developed by Novartis and Genentech. Xolair has been developed for treating a debilitating skin condition that is known as chronic idiopathic urticaria (CIU). The occurrence of this condition is unpredictable, and outside of the United States this disease is also known by another name--chronic spontaneous urticaria (CSU). The company was reported as stating that the drug&rsquo
Date: Mar 28

Telco Industry Demands More Deregulation
AMTA, Communications Alliance supports the ‘red tape’ repeal dealings with the federal government  Since, the federal government reduced the regulations pertaining to the telco and broader communications industries, The Communications Alliance and the Australian Mobile Telecommunications Association (AMTA) have shown a positive reaction to the government’s decision.  Malcolm Turnbull, Communications minister and parliamentary secretary Paul Fletcher state that t
Date: Mar 20

New Porous Materials Demand in the Industry Chemicals and Materials
The industry has come up with new class of making porous materials that significantly controls a wide range of applications and greater manufacturing applications to handle long term industry standard applications.  This discovery was conducted by a team of University of Connecticut chemists that found out the creation of over 60 new families in the field of chemicals and materials. The study was conducted with the potential for many more chemicals and materials. The key purpose in th
Date: Mar 19

Chinese Aging Population Increasingly Turning Towards In-Home Nursing
As China experiences a massive growth in its aged population, it is emerging that many under this category show an inclination towards engaging in-home nursing services. This option is helping families ease the pressure associated with taking care of the aged.  In this backdrop, the Chengguan District Virtual Nursing Home that is located in Gansu province’s Lanzhou city said it will bring on board more healthcare options for the aged. The healthcare agency that offers in-home nursi
Date: Mar 14

Upcoming Reports

Advanced Parenteral Drug Delivery Devices Market - Upcoming Technologies, Current Trends, Global Industry Size, Share, Analysis And Forecast (2012 - 2018)
Increasing number of new biological products and emergence of new biosimilars is focusing the attention towards the development of advanced drug delivery technologies for delivery of these biological products. Currently, oral and parenteral drug delivery technologies are dominating the global drug
Published By: Transparency Market Research
Price: $4795
Needle Free Delivery Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
Worldwide market for needle free delivery devices is forecasted to grow and reach the value of $5.9 billion by the year 2022 driven by the factors like developments in technology and emergence of new products such as micro needle patches and novel jet injectors. This market is expected to bene
Published By: Transparency Market Research
Price: $4795
Genitourinary Drugs Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
Impotency and urinary incontinence are growing concerns among people these days. Technological development is helping to overcome these age-related problems. There are various genitourinary drugs available today to cure the related illnesses.   The genitourinary drugs market is expected
Published By: Transparency Market Research
Price: $4795
Central Nervous System Drug Delivery Specialists Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Despite the advances in brain and central nervous system disorders remains the world’s leading cause of disability. The delivery of drugs to central nervous system remains a challenge for the treatment of nervous system disorders. The major problem faced with drug delivery is the presence of
Published By: Transparency Market Research
Price: $4795
Intranasal Drug Delivery Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Intranasal drug delivery systems administer drugs through nasal route for local or systemic action based on the desired therapeutic modality to the patients. Nasals drugs may be prescribed for acute or chronic treatments and include antibiotics, snuffs, vasoconstrictors, local anesthetics, pain re
Published By: Transparency Market Research
Price: $4795
Nanotechnology Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Nanotechnology has opened a new path for drug delivery to specific cells with the usage of nanoparticles. Nanomedical approach for drug delivery is centered on the development of nanoscale molecules or particles to improve the drug efficiency. Drugs are loaded on nanoparticles or nanocarriers (size
Published By: Transparency Market Research
Price: $4795
Drug Delivery Across The Blood-Brain Barrier Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Blood brain barrier refers to a set of special tight junctions formed around the microvasculature of the brain to gain the optimal neural functioning. The primary function of blood brain barrier is to protect the brain from harmful toxins that are potentially present in the blood stream and allows t
Published By: Transparency Market Research
Price: $4795
Botanical And Plant Derived Drugs Market - Global Industry Analysis, Size, Share, Growth, Trend And Forecast 2013 - 2019
Botanical drugs are drugs develop through botanical drug and research pathway, whereas plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. These botanical products are intended for use in the mitigat
Published By: Transparency Market Research
Price: $4795